Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-064448
Filing Date
2025-05-06
Accepted
2025-05-06 16:07:37
Documents
85
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q acet-20250331.htm   iXBRL 10-Q 2329643
2 EX-31.1 acet-ex31_1.htm EX-31.1 16679
3 EX-31.2 acet-ex31_2.htm EX-31.2 16824
4 EX-32.1 acet-ex32_1.htm EX-32.1 13351
  Complete submission text file 0000950170-25-064448.txt   9659106

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT acet-20250331.xsd EX-101.SCH 1499735
87 EXTRACTED XBRL INSTANCE DOCUMENT acet-20250331_htm.xml XML 1588752
Mailing Address 131 DARTMOUTH STREET 3RD FLOOR BOSTON MA 02116
Business Address 131 DARTMOUTH STREET 3RD FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38359 | Film No.: 25917256
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)